Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.955 USD | -3.08% | +11.41% | +176.63% |
May. 15 | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
May. 15 | Sector Update: Health Care Stocks Rise Pre-Bell Wednesday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+176.63% | 1.07B | |
+7.40% | 113B | |
+11.39% | 106B | |
+0.44% | 22.27B | |
-11.91% | 22.22B | |
-5.99% | 19.43B | |
-37.85% | 17.87B | |
-6.20% | 17.24B | |
+7.17% | 14.29B | |
+34.96% | 12.52B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Insider Sell: Arcutis Biotherapeutics